Buckley David B, Klaassen Curtis D
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7417, USA.
Drug Metab Dispos. 2007 Jan;35(1):121-7. doi: 10.1124/dmd.106.012070. Epub 2006 Oct 18.
UDP-glucuronosyltransferases (UGTs) catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. Currently, little information regarding tissue- or gender-specific expression of mouse UGTs is available. Mice are increasingly popular models in biomedical research, and therefore, thorough characterization of murine drug metabolism is desired. The purpose of the present study was to determine both tissue- and gender-specific UGT gene expression profiles in mice. RNA from 14 tissues was isolated from male and female C57BL/6 mice and UGT expression was determined by the branched DNA signal amplification assay. UGTs highly expressed in mouse liver include Ugt1a1, Ugt1a5, Ugt1a6, Ugt1a9, Ugt2a3, Ugt2b1, Ugt2b5/37/38, Ugt2b34, Ugt2b35, and Ugt2b36. Several isoforms were expressed in the gastrointestinal (GI) tract, including Ugt1a6, Ugt1a7c, Ugt2a3, Ugt2b34, and Ugt2b35. In kidney, Ugt1a2, Ugt1a7c, Ugt2b5/37/38, Ugt2b35, and Ugt3a1/2 were expressed. UGT expression was also observed in other tissues: lung (Ugt1a6), brain (Ugt2b35), testis and ovary (Ugt1a6 and Ugt2b35), and nasal epithelia (Ugt2a1/2). Male-predominant expression was observed for Ugt2b1 in liver, Ugt2b5/37/38 in kidney, and Ugt1a6 in lung. Female-predominant expression was observed for Ugt1a1 and Ugt1a5 in liver, Ugt1a2 in kidney, Ugt2b35 in brain, and Ugt2a1/2 in nasal epithelia. UDP-glucose pyrophosphorylase was highly expressed in liver, kidney, and GI tract, whereas UDP-glucose dehydrogenase was highly expressed in the GI tract. In conclusion, marked differences in tissue- and gender-specific expression patterns of UGTs exist in mice, potentially influencing drug metabolism and pharmacokinetics.
尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)催化II相生物转化反应,在此反应中亲脂性底物与葡萄糖醛酸结合,以增加水溶性并促进排泄。目前,关于小鼠UGTs组织或性别特异性表达的信息很少。小鼠在生物医学研究中越来越成为常用模型,因此,需要全面表征小鼠的药物代谢。本研究的目的是确定小鼠组织和性别特异性的UGT基因表达谱。从雄性和雌性C57BL/6小鼠的14种组织中分离RNA,并通过分支DNA信号放大测定法确定UGT表达。在小鼠肝脏中高表达的UGTs包括Ugt1a1、Ugt1a5、Ugt1a6、Ugt1a9、Ugt2a3、Ugt2b1、Ugt2b5/37/38、Ugt2b34、Ugt2b35和Ugt2b36。几种同工型在胃肠道(GI)中表达,包括Ugt1a6、Ugt1a7c、Ugt2a3、Ugt2b34和Ugt2b35。在肾脏中,表达Ugt1a2、Ugt1a7c、Ugt2b5/37/38、Ugt2b35和Ugt3a1/2。在其他组织中也观察到UGT表达:肺(Ugt1a6)、脑(Ugt2b35)、睾丸和卵巢(Ugt1a6和Ugt2b35)以及鼻上皮(Ugt2a1/2)。在肝脏中观察到Ugt2b1、在肾脏中观察到Ugt2b5/37/38以及在肺中观察到Ugt1a6存在雄性优势表达。在肝脏中观察到Ugt1a1和Ugt1a5、在肾脏中观察到Ugt1a2、在脑中观察到Ugt2b35以及在鼻上皮中观察到Ugt2a1/2存在雌性优势表达。尿苷二磷酸葡萄糖焦磷酸化酶在肝脏、肾脏和胃肠道中高表达,而尿苷二磷酸葡萄糖脱氢酶在胃肠道中高表达。总之,小鼠UGTs的组织和性别特异性表达模式存在显著差异,这可能影响药物代谢和药代动力学。